Difficulty: Medium
Average Score: 84%
Practice
A 22-year-old African American man who is a college student plans to travel to Africa for a semester of study abroad. A university student health physician prescribes chloroquine for malaria prophylaxis starting 2 weeks before the trip. Soon after starting the regimen, the patient develops scleral icterus. What is the most likely underlying cause for the icterus?
Correct answer
D
Rationale
The correct answer is D) Enzyme deficiency. In this scenario, the patient's development of scleral icterus (yellowing of the eyes) after starting chloroquine for malaria prophylaxis suggests an underlying glucose-6-phosphate dehydrogenase (G6PD) deficiency. G6PD deficiency is an inherited enzyme deficiency that can lead to hemolysis when exposed to certain drugs like chloroquine. This hemolysis results in the release of bilirubin, causing icterus.
Option A) Biliary sludging is incorrect because the presentation of scleral icterus is not typical of biliary sludging. Option B) Chloroquine simply turns tears yellow is incorrect because icterus is a sign of bilirubin accumulation, not a color change from the drug. Option C) Drug interaction is less likely in this case compared to an enzyme deficiency.
Understanding the relationship between G6PD deficiency and drug-induced hemolytic anemia is crucial for healthcare professionals, especially when prescribing medications to patients with this deficiency. Recognizing the signs and symptoms of hemolysis can prevent serious complications. This question also highlights the importance of considering a patient's individual genetic makeup and medical history when prescribing medications to ensure safe and effective treatment.
Option A) Biliary sludging is incorrect because the presentation of scleral icterus is not typical of biliary sludging. Option B) Chloroquine simply turns tears yellow is incorrect because icterus is a sign of bilirubin accumulation, not a color change from the drug. Option C) Drug interaction is less likely in this case compared to an enzyme deficiency.
Understanding the relationship between G6PD deficiency and drug-induced hemolytic anemia is crucial for healthcare professionals, especially when prescribing medications to patients with this deficiency. Recognizing the signs and symptoms of hemolysis can prevent serious complications. This question also highlights the importance of considering a patient's individual genetic makeup and medical history when prescribing medications to ensure safe and effective treatment.